To reach a definitive diagnosis of FDCS, FDC markers, such as CD21, CD35, Ki-M4p, and CNA.42, are used to distinguish it from other tumors that may have a mesenchymal structure, such as undifferentiated carcinoma, meningioma, and paraganglioma [7, 8]. The gene discussed is CR1; the disease is paraganglioma.